Evolent Health, Inc (EVH) financial statements (2021 and earlier)
Company profile
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019
| 12/31/2018
| 12/31/2017
| 12/31/2016
| 12/31/2015
|
|
ASSETS |
|
Current Assets |
|
Cash, cash equivalents, and short-term investments | 103 | 228 | 238 | 179 | 155 |
|
Cash and cash equivalents | 101 | 228 | 238 | 135 | 146 |
|
Short-term investments | 2 | | | 44 | 9 |
|
Restricted cash and investments | 20 | 155 | 62 | 34 | 5 |
|
Receivables | 72 | 78 | 75 | 51 | 20 |
|
Contract with customer, asset | 2 | 2 | ✕ | ✕ | ✕ |
|
Other undisclosed current assets | 32 | 24 | 3 | 1 | 4 |
|
Total current assets: | 229 | 488 | 378 | 265 | 184 |
|
Noncurrent Assets |
|
Operating lease, right-of-use asset | 72 | ✕ | ✕ | ✕ | ✕ |
|
Property, plant and equipment | 85 | 74 | 51 | 31 | 13 |
|
Long-term investments and receivables | 140 | 13 | 2 | 2 | 45 |
|
Long-term investments | 139 | 6 | 2 | 2 | 45 |
|
Accounts and financing receivable, after allowance for credit loss | 1 | 7 | | | |
|
Intangible assets, net (including goodwill) | 881 | 1,103 | 869 | 885 | 772 |
|
Goodwill | 572 | 768 | 628 | 627 | 609 |
|
Intangible assets, net (excluding goodwill) | 308 | 335 | 241 | 259 | 163 |
|
Contract with customer, asset, net | 1 | 1 | ✕ | ✕ | ✕ |
|
Capitalized contract cost, net | 36 | 19 | ✕ | ✕ | ✕ |
|
Restricted cash and investments | 8 | 6 | 3 | 6 | 2 |
|
Other undisclosed noncurrent assets | 46 | 18 | 9 | 10 | |
|
Total noncurrent assets: | 1,269 | 1,234 | 935 | 935 | 831 |
|
TOTAL ASSETS: | 1,498 | 1,722 | 1,313 | 1,200 | 1,016 |
|
LIABILITIES AND EQUITY |
|
Liabilities |
|
Current Liabilities |
|
Accounts payable and accrued liabilities | 106 | 221 | 108 | 111 | 45 |
|
Accounts payable | 37 | 147 | 43 | 44 | 17 |
|
Accrued liabilities | 33 | 49 | 30 | 29 | 6 |
|
Employee-related liabilities | 35 | 25 | 35 | 38 | 22 |
|
Deferred revenue | 20 | ✕ | ✕ | ✕ | ✕ |
|
Debt | 6 | | | | |
|
Due to related parties | | 1 | | | |
|
Deferred revenue and credits | ✕ | ✕ | 25 | 20 | 15 |
|
Contract with customer, liability | ✕ | 21 | ✕ | ✕ | ✕ |
|
Other undisclosed current liabilities | 61 | 27 | | | |
|
Total current liabilities: | 193 | 269 | 133 | 132 | 60 |
|
Noncurrent Liabilities |
|
Long-term debt and lease obligation | 69 | | | | |
|
Operating lease, liability | 69 | ✕ | ✕ | ✕ | ✕ |
|
Liabilities, other than long-term debt | 15 | 19 | 12 | 36 | 21 |
|
Deferred revenue | 1 | ✕ | ✕ | ✕ | ✕ |
|
Contract with customer, liability | ✕ | 2 | ✕ | ✕ | ✕ |
|
Deferred tax liabilities, net | ✕ | | 2 | 21 | 21 |
|
Deferred income tax liabilities | 2 | ✕ | ✕ | ✕ | ✕ |
|
Other liabilities | 12 | 17 | 10 | 15 | 0 |
|
Other undisclosed noncurrent liabilities | 292 | 245 | 121 | 120 | |
|
Total noncurrent liabilities: | 376 | 264 | 134 | 156 | 21 |
|
Total liabilities: | 569 | 533 | 266 | 288 | 81 |
|
Stockholders' equity |
|
Stockholders' equity attributable to parent, including: | 922 | 1,144 | 1,011 | 703 | 649 |
|
Additional paid in capital | 1,174 | 1,093 | 924 | 555 | 342 |
|
Accumulated other comprehensive loss | (0) | (0) | | | |
|
Retained earnings (accumulated deficit) | (252) | 50 | 86 | 147 | 307 |
|
Other undisclosed stockholders' equity attributable to parent | 1 | 1 | 1 | 1 | 1 |
|
Stockholders' equity attributable to noncontrolling interest | 7 | 46 | 35 | 210 | 285 |
|
Total stockholders' equity: | 929 | 1,189 | 1,046 | 912 | 935 |
|
TOTAL LIABILITIES AND EQUITY: | 1,498 | 1,722 | 1,313 | 1,200 | 1,016 |
Income statement (P&L) ($ in millions)
Comprehensive Income ($ in millions)
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission
(SEC)
through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from
the 10-K and 10-Q reports submitted
to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP
Taxonomy.
Please review the original filings
for a more detailed information.